Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype

British Journal of Haematology

Volumn 95, Issue 3, 1996, Pages 452-456

  Zehrer, Cornelia ^a   Beck, James ^a   Gekeler, Volker ^b   Ihle, Johannes ^a   Holzer, Ursula ^a   Dohlsten, Mikael ^c   Kalland, Terje ^c   Niethammer, Dietrich ^a   Dannecker, Günther E ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c Pharmacia Oncology Immunology   (Sweden)

Author keywords

Cytotoxic T cells; Monoclonal antibodies; Multidrug resistance; P glycoprotein; Superantigen

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; SUPERANTIGEN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0029910946     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1938.x     Document Type: Article

References (18)

1. Abrahmsen, L., Dohlsten, M., Segren, S., Bjork, P., Jonsson, E. & Kalland, T. (1995) Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO Journal, 14, 2978-2986.
2. Arceci, R., Stieglitz, K., Bras, J., Schinkel, A., Baas, F. & Croop, J. (1993) Monoclonal antibody to an external epitope of the human mdr1 p-glycoprotein. Cancer Research, 53, 310-317.
3. Beck, J., Handgretinger, R., Dopfer, R., Klingebiel, T., Niethammer, D. & Gekeler, V. (1995) Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. British Journal of Haematology, 89, 356-363.
4. Boesch, D., Gaveriaux, C., Jachez, B., Pourtier Manzanedo, A., Bollinger, P. & Loor, F. (1991) In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Research, 51, 4226-4233.
5. Chan, H.S.L., DeBoer, G., Haddad, G., Gallie, B.L. & Ling, V. (1995) Multidrug resistance in pediatric malignancies. Hematology Oncology Clinics of North America, 9, 275-318.
6. Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94.
7. Dohlsten, M., Hansson, J., Ohlsson, L., Litton, M. & Kalland, T. (1995) Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo. Proceedings of the National Academy of Sciences of the United States of America, 92, 9791-9795.
8. Dohlsten, M., Lando, P.A., Hedlund, G., Trowsdale, J. & Kalland, T. (1990) Targeting of human T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. Immunology, 71, 96-100.
9. Gekeler, V., Frese, G., Noller, A., Handgretinger, R., Wilisch, A., Schmidt, H., Muller, C., Dopfer, R., Klingebiel, T., Diddens, H., Probst, H. & Niethammer, D. (1992) Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. British Journal of Cancer, 66, 507-517.
10. Gottesman, M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Reviews of Biochemistry, 62, 385-427.
11. 2-positive neuroblasloma cells. Cancer Immunology and Immunotherapy, 41, 129-136.
12. Ihle, J., Holzer, U., Krull, F., Dohlsten, M., Kalland, T., Niethammer, D. & Dannecker, G.E. (1995) Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines. Cancer Research, 55, 623-628.
13. Kimmig, A., Gekeler, V., Neumann, M., Frese, G., Handgretinger, R., Kardos, G., Diddens, H. & Niethammer, D. (1990) Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Research, 50, 6793-6799.
14. Mickisch, G.H., Pai, L.H., Siegsmund, M., Campain, J., Gottesman, M.M. & Pastan, I. (1993) Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in cultured renal carcinomas and in MDR-transgenic mice. Journal of Urology, 149, 174-178.
15. Mooney, E.F., Dye, J.F., Guillou, P.J. & Monson, J.R. (1993) Multidrug-resistant colonic cancer cell line LoVoDx is efficiently killed by lymphokine-activated killer cells from patients with carcinoma of the colon. British Journal of Surgery, 80, 1259-1261.
16. Nilsson, B., Moks, T., Jansson, B., Abrahmsen, L., Elmblad, A., Holmgren, E., Henrichson, C., Jones, T.A. & Uhlen, M. (1987) A synthetic IgG-binding domain based on staphylococcal protein A. Protein Engineering, 1, 107-113.
17. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. & Willingham, M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 7735-7738.
18. Van de Vrie, W., Van der Heyden, S.A., Gheuens, E.E., Bijma, A.M., De Bruijn, E.A., Marquet, R.L., Van Oosterom, A.T. & Eggermont, A.M. (1993) Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells. Cancer Immunology and Immunotherapy, 37, 337-342.